Top compounds associated with response to BLMH


Feature Type Standardized
Nominal ANOVA
mRNA carboplatin:etoposide (40:17 mol/mol) CTRPv2 pan-cancer AAC 0.16 1e-06
mRNA docetaxel:tanespimycin (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.17 1e-06
mRNA FQI-2 CTRPv2 pan-cancer AAC 0.17 1e-06
mRNA paclitaxel CTRPv2 pan-cancer AAC 0.17 2e-06
mRNA selumetinib:UNC0638 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.18 3e-06
mRNA Topotecan CCLE pan-cancer AAC 0.21 3e-06
mRNA decitabine CTRPv2 pan-cancer AAC 0.14 3e-06
mRNA Vorinostat gCSI pan-cancer AAC 0.24 3e-06
mRNA Axitinib CTRPv2 pan-cancer AAC 0.17 4e-06
mRNA Gemcitabine CTRPv2 pan-cancer AAC 0.17 4e-06
Download CSV